Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells
Keywords: Nanomedicine; Drug targeting; Coordination chemistry; Kinase inhibitor; Clathrin-mediated endocytosis; Engineered antibodies;